What a sample packet should make visible
| Packet layer | What to show | What it cannot decide |
|---|---|---|
| Intended-use note | Plain-language use, user, setting, and product boundary. | The final regulatory intended use. |
| Product-code clues | Candidate public classification entries and why they were considered. | The correct product code or class. |
| Similar-device rows | Candidate 510(k) records and same/different notes. | Predicate suitability or substantial equivalence. |
| Safety-history scan | Manufacturer and User Facility Device Experience, recall, or warning-letter source checks. | Safety, reportability, recall, or compliance conclusions. |
Why the sample should not look like an answer key
A useful Product ID sample shows the shape of the evidence packet, not a finished regulatory strategy. The reader should be able to see where public records support a question and where qualified reviewers must decide.
That distinction is the point of the sample: a founder can understand what they are buying without mistaking the packet for Food and Drug Administration, consultant, or legal judgment.
What TrueMedDevice can prepare
TrueMedDevice can prepare a Product ID evidence packet with source links, candidate clues, similar-device rows, safety-history prompts, and consultant handoff questions.
Source ledger
What it can tell you
FDA's public entry points for device databases and research.
What it cannot decide
Which database results are sufficient for a specific product's strategy.
What it can tell you
Public product-code and classification entries that may help frame candidate questions.
What it cannot decide
The product code, class, or pathway for a specific device.
What it can tell you
Public 510(k) records, K numbers, applicants, product codes, and decision information.
What it cannot decide
Predicate suitability or substantial equivalence for a new device.
What it can tell you
FDA's structured electronic submission template context.
What it cannot decide
Whether a specific product's evidence is sufficient for a submission.
Frequently asked questions
Is a Product ID sample the same as a regulatory strategy?
No. It shows the evidence artifact and review questions. Regulatory strategy remains a qualified professional and company decision.
Why include source limits in a sample?
Because public records can show useful clues but cannot decide the product-specific regulatory answer. The source limit prevents the sample from overclaiming.
Can the same packet support multiple consultant conversations?
Yes. A source-backed packet can be reused because it preserves the public evidence, query path, date checked, and unresolved questions.
Want a Product ID packet for your own device?
TrueMedDevice can prepare the source ledger, candidate clues, evidence map, and open questions before consultant review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.